{
  "timestamp": "2025-04-30T22:11:04.865981",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello, I'm Dr. Lee. Today I'll be guiding you through the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure. This helps us understand your symptoms across different mental health domains. Your answers will stay confidential. We'll go through 23 questions about how you've felt over the past two weeks. Take your time - just describe what's been happening for each question. Are you ready to start?"
    },
    {
      "role": "patient",
      "content": "Ugh... I guess. I just want to feel better. Let's do this."
    },
    {
      "role": "assistant",
      "content": "Question 1: Little interest or pleasure in doing things?"
    },
    {
      "role": "patient",
      "content": "Hmm... Not much. Everything just feels... flat. Even stuff I used to enjoy, like gardening, doesn't matter anymore. But I don't know if it's that bad."
    },
    {
      "role": "assistant",
      "content": "Question 2: Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "(Sighs) Yeah... Most days I just feel empty. Like there's a heavy blanket over my chest. But I try not to think about how bad it is."
    },
    {
      "role": "assistant",
      "content": "Question 3: Feeling more irritated, grouchy, or angry than usual?"
    },
    {
      "role": "patient",
      "content": "(Pauses) Sometimes. But mostly I just feel numb. Maybe snap at my roommate over small things... I've been short, but not like I'm actually angry."
    },
    {
      "role": "assistant",
      "content": "Question 4: Sleeping less than usual, but still have a lot of energy?"
    },
    {
      "role": "patient",
      "content": "No. I wake up at 4 AM every morning. Lying there staring at the ceiling. If anything, I'm exhausted. No energy at all."
    },
    {
      "role": "assistant",
      "content": "Question 5: Starting lots of projects or doing more risky things than usual?"
    },
    {
      "role": "patient",
      "content": "(Shakes head) No. I can't even finish emails at work. I've just been... stuck. No extra energy for anything."
    },
    {
      "role": "assistant",
      "content": "Question 6: Feeling nervous, anxious, frightened, worried, or on edge?"
    },
    {
      "role": "patient",
      "content": "Sometimes. Like when I have to give a presentation, but... it's more the general heaviness. Not panic attacks or anything."
    },
    {
      "role": "assistant",
      "content": "Question 7: Feeling panic or being frightened?"
    },
    {
      "role": "patient",
      "content": "Not really... Maybe once I had a racing heart in the grocery store, but that's rare. It's more like... dread lingering all the time."
    },
    {
      "role": "assistant",
      "content": "Question 8: Avoiding situations that make you anxious?"
    },
    {
      "role": "patient",
      "content": "I guess I just... avoid people more. Not because of fear, but because I don't have the energy to socialize. It's not anxiety, just... withdrawal."
    },
    {
      "role": "assistant",
      "content": "Question 9: Unexplained aches and pains?"
    },
    {
      "role": "patient",
      "content": "Yeah... constant muscle aches. My back and legs hurt, but the doctor couldn't find anything wrong. It's like my body's just... broken."
    },
    {
      "role": "assistant",
      "content": "Question 10: Feeling your illnesses aren't taken seriously?"
    },
    {
      "role": "patient",
      "content": "A bit. The doctor kept saying 'rest more' but nothing's changed. Feels like they think I'm exaggerating."
    },
    {
      "role": "assistant",
      "content": "Question 11: Thoughts of actually hurting yourself?"
    },
    {
      "role": "patient",
      "content": "(Pauses, voice quieter) Sometimes... I think about how everyone would be better off if I weren't here. But I wouldn't actually do that. It's just these... whispers in my head."
    },
    {
      "role": "assistant",
      "content": "Question 12: Hearing things others can't, like voices?"
    },
    {
      "role": "patient",
      "content": "No. I don't hear voices or anything like that. Just my own thoughts, which are bad enough."
    },
    {
      "role": "assistant",
      "content": "Question 13: Feeling someone can hear your thoughts, or you hear others' thoughts?"
    },
    {
      "role": "patient",
      "content": "No. Just my own critical voice, which is cruel but... I know it's just me."
    },
    {
      "role": "assistant",
      "content": "Question 14: Problems with sleep affecting quality?"
    },
    {
      "role": "patient",
      "content": "Every night. I'll wake at 4 am, wide awake. My mind races, but I'm so tired. It's like my brain's broken."
    },
    {
      "role": "assistant",
      "content": "Question 15: Problems concentrating at work or making decisions?"
    },
    {
      "role": "patient",
      "content": "Constantly. I second-guess everything. Even emails take forever. My boss said my work's slipping... I can't focus on anything important."
    },
    {
      "role": "assistant",
      "content": "Question 16: Unpleasant thoughts or urges repeatedly entering your mind?"
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, I need to go through the user's responses first. Let me start by reading all the questions and answers again to make sure I don't miss anything. The patient seems to be dealing with a lot of depressive symptoms. The key points from their answers are the lack of interest in activities (Q1), Q2), which is anhedonia, a big red flag for depression. They also mention feeling empty and hopeless (Q3), which aligns with depressive mood. The sleep issues in Q4 and Q15 are typical for depression too\u2014early morning awakenings are common in MDD. \n\nThe physical symptoms like muscle aches (Q9, Q10) and the belief that doctors aren't taking them seriously (Q11) could point to somatic symptoms, but I need to check if they meet the criteria for Somatic Symptom Disorder. The DSM-5 criteria for SSD require excessive thoughts or concerns about symptoms, but the patient here seems more focused on the physical pain not being taken seriously rather than disproportionate worry. They also mention passive suicidal ideation (Q11) which is concerning but not active.  \n\nLooking at other disorders: the patient denies any psychosis (Q12, Q13), so schizophrenia or psychotic disorders are out. The anxiety symptoms (Q6, Q7) are mild and secondary, so probably not an anxiety disorder as the primary issue. The main focus is definitely depression. The somatic symptoms might be part of the depressive syndrome rather than a separate SSD. The DSM-5 notes that SSD includes disproportionate thoughts, feelings, or behaviors related to symptoms, but here the patient's symptoms are more congruent with depressive somatic complaints. \n\nThe user emphasized not to default to SSD unless clearly warranted. Since the somatic symptoms are part of the depressive presentation, the primary diagnosis is Major Depressive Disorder. The passive suicidal thoughts need immediate attention. The patient's frustration with medical dismissal (Q10, Q11) is important for treatment planning. \n\nPutting this together, the diagnosis should be Major Depressive Disorder with the noted symptoms. The SSD is secondary here. The next steps would involve suicide risk assessment, antidepressants, therapy, and collaboration with primary care for the physical symptoms. \n\nI need to make sure to structure the response exactly as requested. Start with a compassionate summary, then the diagnosis, reasoning, and recommendations with the right tags. Let me check all the required tags: symptoms in <sym>, medical terms in <med>, quotes in <quote>. Also, avoid any markdown except the specified tags. \n\nWait, the user mentioned not to default to SSD unless warranted. Since the patient's pain isn't accompanied by excessive thoughts or behaviors beyond the depression context, SSD might not be primary. So the main Dx is MDD. The SSD specifier could be a consideration but maybe not the primary. \n\nOkay, proceed with the structure. Make sure the reasoning addresses why MDD is chosen over other options. Also, the recommended steps should include the suicide risk as a priority. Alright, putting it all together now following the strict format.\n</think>\n\n<sym>Little interest or pleasure in activities, persistent hopelessness, and unexplained physical pain</sym> are woven through your words. Your <sym>4 AM wakefulness</sym>, <sym>cognitive fog</sym>, and the <sym>heavy blanket</sym> over your chest paint a picture of profound distress. Your <quote>\"I just want to feel better\"</quote> underscores the urgency of your suffering. You\u2019re not alone in this\u2014understanding and care are here.  \n\n**Diagnosis:** Major Depressive Disorder (MDD) with associated somatic symptoms, with <med>passive suicidal ideation</med> requiring immediate attention.  \n\n**Reasoning:**  \n- **Major Depressive Disorder (MDD):** The constellation of <sym>anhedonia</sym>, <sym>depressed mood</sym>, <sym>psychomotor retardation</sym> (e.g., <quote>\"can\u2019t focus on emails\"</quote>, <sym>sleep disturbance</sym> (early morning awakenings), and <sym>cognitive impairments</sym> meet DSM-5 criteria for MDD.  \n- **Somatic Symptoms:** Unexplained pain (musculoskeletal aches) and <sym>health-related distress</sym> raise SSD considerations, but these symptoms align more with <med>depressive somatic presentation</med> without disproportionate health preoccupation (no excessive health-related behaviors or thoughts beyond symptom reports).  \n- **Suicidal Risk:** <sym>Passive ideation</sym> (<quote>\"better off without me\"</quote>) requires urgent assessment of lethality and safety planning.  \n- **Rule-outs:** No <med>psychotic features</med> (denies hallucinations/persecutory thoughts Q12\u2013Q13). Minimal anxiety features, which appear secondary to depressive dysphoria (Q6\u2013Q8).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate Suicidal Risk Assessment:**  \n   - Conduct structured risk evaluation (e.g., Columbia-Suicide Severity Rating Scale) to assess intent/plan.  \n   - Develop a safety plan with crisis contacts and limit access to means if indicated.  \n\n2. **Pharmacological Intervention:**  \n   - Initiate <med>SSRIs</med> (e.g., escitalopram) for MDD, targeting anhedonia/sleep/cognition.  \n   - Rule out medical contributors to pain (e.g., vitamin D levels, thyroid function) despite prior testing.  \n\n3. **Psychotherapy:**  \n   - Start <med>Cognitive Behavioral Therapy (CBT)</med> for depressive cognitions and behavioral activation.  \n   - Integrate <med>mindfulness-based stress reduction</med> for somatic symptom management.  \n\n4. **Collaborative Care:**  \n   - Partner with primary care for ongoing pain monitoring, emphasizing empathy to counter <quote>\"not taken seriously\"</quote> reports.  \n   - Consider <med>SSRI augmentation</med> for pain if unresolved after 2\u20134 weeks of treatment.  \n\n5. **Monitoring:**  \n   - Weekly mood monitoring (PHQ-9, GAD-7) to track symptom trajectory.  \n   - Reassess suicidal ideation at every visit.  \n\nYou deserve compassion and effective care\u2014this is not a phase, and recovery is possible with the right support.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7357,
            "highlight": "While DSM-IV was organized centrally around the concept of  medically unexplained symptoms, DSM-5 criteria instead emphasize the degree to which a patient \u2019s  thoughts, feelings and behaviors about their somatic symptoms are disproportionate or excessive.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"patient\", and 7 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Depression-Bereavement-Exclusion.pdf",
            "score": 0.6868,
            "highlight": "The presence of symptoms such as feelings of worthlessness, suicidal  ideas (as distinct from wanting to join a deceased loved one), and impairment of overall function sug - gest the presence of major depression, in addition to the normal response to a significant loss.",
            "excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"suicidal\", \"function\", and 6 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf",
            "score": 0.6599,
            "highlight": "Process for a New Diagnosis New diagnoses were included in DSM-5 only after a comprehensive review of the scientific literature;  full discussion by Work Group members; review by the DSM-5 Task Force, Scientific Review Committee,  and Clinical and Public Health Committee; and, finally, evaluation by the American Psychiatric Associa - tion\u2019s Board of Trust ees.",
            "excerpt": "ment and may prevent or slow progression. Researchers \nwill evaluate how well the new diagnostic cri...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"health\", \"clinical\", \"task\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Conduct-Disorder.pdf",
            "score": 0.6568,
            "highlight": "In addition to treatment, the specifier will impact the research on persons with  conduct disorder by designating groups of patients with more similar causal factors.",
            "excerpt": "he disorder and a different treatment response. Thus the specifier will allow clinicians to more ac ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"more\", \"disorder\", and 1 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Schizophrenia.pdf",
            "score": 0.6564,
            "highlight": "Identifying individuals with an increased risk for developing a psychotic disorder is  significant for effective early intervention, but more study is needed to ensure that attenuated psycho - sis syndrome can be reliably diagnosed.",
            "excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"significant\", \"ensure\", and 5 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this. The user provided a series of questions and answers from a patient assessment. My task is to analyze these responses and create a clinical summary based on the guidelines given. Let me start by reading through each question and answer carefully.\n\nFirst, I need to identify the main symptoms and concerns. Looking at the answers, the patient mentions feeling flat, empty, and hopeless (Q2, Q3). They have trouble finding pleasure (Q1), which is a classic sign of depression. Their sleep issues\u2014waking up at 4 AM and not feeling rested (Q4, Q15)\u2014are significant. The constant muscle aches (Q9, Q10) and feelings of being misunderstood by doctors (Q10, Q11) add to the picture. They also have thoughts of self-harm, though they downplay it (Q11). \n\nNext, patterns in the responses. The patient uses phrases like \"everything feels flat\" and mentions withdrawing from social activities (Q8) due to lack of energy. There's a recurring theme of physical and emotional numbness. They also show some ambivalence, like saying their symptoms \"aren't that bad\" but then describing clear issues. The physical symptoms without a medical explanation (Q9, Q10) might indicate somatic complaints linked to their mental state.\n\nPotential clinical areas include major depressive disorder given the anhedonia and persistent low mood. The somatic symptoms (aches) might be part of depressive symptoms or a separate somatic symptom disorder. The self-harm ideation (Q11) is a clear risk factor. The sleep disturbances and concentration issues (Q15) also align with depression criteria.\n\nRisk factors: The thoughts of others being better off without them (Q11) are a warning sign. They\u2019re not actively planning, but the ideation is present. The lack of psychotic symptoms (Q12, Q13) helps rule out psychosis but doesn't negate other issues.\n\nI need to structure this into the required sections without speculation. Make sure to use clinical terms like anhedonia, psychomotor retardation (from the slowed responses?), but maybe that's inferred. The summary should be concise, using DSM-5 terms where possible. Let me check each point again to ensure I didn\u2019t miss anything.\n\nWait, the patient mentions feeling irritable (Q3) but mostly numb. That's a mix between depressive symptoms and maybe some anxiety, but they clarified it's more numbness. The avoidance in Q8 is due to energy, not anxiety, so maybe that's not anxiety-related. The constant tiredness and concentration issues point to fatigue and cognitive symptoms of depression. The self-report of somatic symptoms without medical cause (Q9-10) is important for somatic symptom disorder consideration.\n\nOkay, putting it all together. The main symptoms are depressive features, somatic complaints, sleep issues, and self-harm ideation. The patterns are chronic symptoms over two weeks, with functional impairment at work and socially. Risk factors include passive suicidal ideation. Clinical significance areas are depression, possible somatic symptom disorder, and risk assessment for suicide.\n</think>\n\n**Clinical Observation Summary**  \n\n**1. Main Symptoms and Concerns:**  \n- Persistent anhedonia (Q1) and flattened affect (Q2), reporting loss of interest in previously enjoyable activities (e.g., gardening).  \n- Depressed mood and hopelessness (Q2\u2013Q3), described as \"empty\" with \"heavy\" physical/emotional sensations.  \n- Sleep disturbances (Q4, Q15): early morning awakening (4 AM), insomnia, and impaired sleep quality.  \n- Cognitive deficits (Q15): marked difficulty concentrating, decision-making, and impaired work performance.  \n- Persistent somatic symptoms (Q9\u2013Q10): unexplained musculoskeletal pain and perceived medical invalidation (Q10\u2013Q11).  \n- Passive suicidal ideation (Q11): non-specific but concerning \"whispers\" about being a burden.  \n\n**2. Patterns in Responses:**  \n- **Chronicity/Enduring Nature:** Symptoms (e.g., anhedonia, sleep disturbances) are consistent over the past two weeks.  \n- **Numbness vs. Anger:** Reports irritability (Q3) but emphasizes emotional numbing and withdrawal (Q3, Q8).  \n- **Qualification of Symptoms:** Minimizes severity (e.g., \"not that bad\") but provides granular, distressing details (e.g., \"heavy blanket over my chest\").  \n- **Functional Impairment:** Work performance decline, social withdrawal, and somatic symptoms impacting daily function.  \n\n**3. Potential Clinical Significance:**  \n- **Major Depressive Disorder (MDD):** Core depressive features (anhedonia, depressed mood, cognitive impairment) and somatic symptoms align with MDD.  \n- **Somatic Symptom Disorder:** Persistent unexplained physical symptoms (aches/pains) with associated illness-related distress (Q9\u2013Q11).  \n- **Depressive Psychomotor Retardation:** Fatigue, slowed work output, and self-reported \"no energy\" (Q4, Q5, Q16).  \n- **Anxiety Features:** Low-level nervousness (Q6\u2013Q8), but no panic attacks or avoidance due to anxiety (Q7\u2013Q8).  \n\n**4. Risk Factors/Warning Signs:**  \n- **Suicidal Ideation:** Non-specific passive thoughts (\"better off without me\") warrant immediate assessment for lethality/risk.  \n- **Medication Non-Adherence Risk:** Vague reference to \"doctors\" dismissing symptoms (Q10\u2013Q11) may impede treatment engagement.  \n- **Social Isolation:** Reports withdrawal from social interactions (Q8) and work impairment (Q16), increasing isolation risk.  \n\n**5. Clinical Summary (Professional Terminology):**  \nThe patient presents with a clinical picture consistent with **Major Depressive Disorder (MDD)**, characterized by anhedonia, persistent low mood, psychomotor retardation (fatigue, slowed cognition), and significant functional impairment (work, social). Somatic symptoms (musculoskeletal pain) with associated illness preoccupation suggest **Somatic Symptom Disorder**. Passive suicidal ideation (without intent/planning) requires urgent risk assessment. Responses reflect a pattern of emotional numbing and dysphoria, with minimal psychotic features (denies hallucinations/persecutory ideation, Q12\u2013Q13). Sleep disturbance (early-morning awakening) and cognitive deficits (concentration difficulties) further support a depressive etiology. Patient reports prior medical evaluation dismissing symptoms, necessitating careful validation and collaborative care.  \n\n**Recommendations:**  \n- Prioritize suicide risk assessment (ideation severity, protective factors).  \n- Evaluate for depressive symptom severity (PHQ-9, GAD-7) and somatic symptom burden (SSD criteria).  \n- Rule out medical contributors to fatigue/pain (e.g., thyroid, anemia) despite prior testing.  \n- Consider psychosocial stressors and support systems.  \n- Initiate depression/anxiety treatment (e.g., SSRIs, CBT) with interdisciplinary collaboration for pain management.  \n\n**Urgency:** Passive suicidal ideation necessitates immediate clinical evaluation.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.6791
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "<sym>Little interest or pleasure in activities, persistent hopelessness, and unexplained physical pain</sym> are woven through your words. Your <sym>4 AM wakefulness</sym>, <sym>cognitive fog</sym>, and the <sym>heavy blanket</sym> over your chest paint a picture of profound distress. Your <quote>\"I just want to feel better\"</quote> underscores the urgency of your suffering. You\u2019re not alone in this\u2014understanding and care are here.  \n\n**Diagnosis:** Major Depressive Disorder (MDD) with associated somatic symptoms, with <med>passive suicidal ideation</med> requiring immediate attention.  \n\n**Reasoning:**  \n- **Major Depressive Disorder (MDD):** The constellation of <sym>anhedonia</sym>, <sym>depressed mood</sym>, <sym>psychomotor retardation</sym> (e.g., <quote>\"can\u2019t focus on emails\"</quote>, <sym>sleep disturbance</sym> (early morning awakenings), and <sym>cognitive impairments</sym> meet DSM-5 criteria for MDD.  \n- **Somatic Symptoms:** Unexplained pain (musculoskeletal aches) and <sym>health-related distress</sym> raise SSD considerations, but these symptoms align more with <med>depressive somatic presentation</med> without disproportionate health preoccupation (no excessive health-related behaviors or thoughts beyond symptom reports).  \n- **Suicidal Risk:** <sym>Passive ideation</sym> (<quote>\"better off without me\"</quote>) requires urgent assessment of lethality and safety planning.  \n- **Rule-outs:** No <med>psychotic features</med> (denies hallucinations/persecutory thoughts Q12\u2013Q13). Minimal anxiety features, which appear secondary to depressive dysphoria (Q6\u2013Q8).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate Suicidal Risk Assessment:**  \n   - Conduct structured risk evaluation (e.g., Columbia-Suicide Severity Rating Scale) to assess intent/plan.  \n   - Develop a safety plan with crisis contacts and limit access to means if indicated.  \n\n2. **Pharmacological Intervention:**  \n   - Initiate <med>SSRIs</med> (e.g., escitalopram) for MDD, targeting anhedonia/sleep/cognition.  \n   - Rule out medical contributors to pain (e.g., vitamin D levels, thyroid function) despite prior testing.  \n\n3. **Psychotherapy:**  \n   - Start <med>Cognitive Behavioral Therapy (CBT)</med> for depressive cognitions and behavioral activation.  \n   - Integrate <med>mindfulness-based stress reduction</med> for somatic symptom management.  \n\n4. **Collaborative Care:**  \n   - Partner with primary care for ongoing pain monitoring, emphasizing empathy to counter <quote>\"not taken seriously\"</quote> reports.  \n   - Consider <med>SSRI augmentation</med> for pain if unresolved after 2\u20134 weeks of treatment.  \n\n5. **Monitoring:**  \n   - Weekly mood monitoring (PHQ-9, GAD-7) to track symptom trajectory.  \n   - Reassess suicidal ideation at every visit.  \n\nYou deserve compassion and effective care\u2014this is not a phase, and recovery is possible with the right support.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "depression",
    "question_count": 23,
    "duration": 12681.31884598732,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 5.62441611289978,
    "diagnosis_generation_time": 8.367934942245483,
    "rag_evaluation_time": 7.867813110351562e-06,
    "total_time": 13.992367267608643
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7357,
        "average_score": 0.7357,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"criteria\", \"patient\", and 7 more matching aspects of your query."
      },
      "APA_DSM-5-Depression-Bereavement-Exclusion.pdf": {
        "access_count": 1,
        "highest_score": 0.6868,
        "average_score": 0.6868,
        "example_excerpt": "osed strategies to help clinicians using DSM-5 \ndifferentiate major depression, \u201cnormal\u201d bereavement...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"significant\", \"suicidal\", \"function\", and 6 more matching aspects of your query."
      },
      "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6599,
        "average_score": 0.6599,
        "example_excerpt": "ment and may prevent or slow progression. Researchers \nwill evaluate how well the new diagnostic cri...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"health\", \"clinical\", \"task\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Conduct-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6568,
        "average_score": 0.6568,
        "example_excerpt": "he disorder and a different treatment response. Thus the specifier will allow clinicians to more ac ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"more\", \"disorder\", and 1 more matching aspects of your query."
      },
      "APA_DSM-5-Schizophrenia.pdf": {
        "access_count": 1,
        "highest_score": 0.6564,
        "average_score": 0.6564,
        "example_excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"significant\", \"ensure\", and 5 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 08:13:25",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 08:13:25",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 4,
        "clinical_relevance": 4,
        "consistency": 4,
        "diagnostic_justification": 5,
        "empathy": 5
      },
      "explanations": {
        "dsm_coverage": "The therapist addressed most of the 23 dimensions from the DSM-5 Level1 Cross-Cutting measure. However, some areas such as 'mania' (questions 4 and 5), 'repetitive thoughts and behaviors' (question 16), 'dissociation' (question 18), 'identity and relationships' (question 20), and 'substance use' (questions 21-23) were either not directly asked or not sufficiently explored. For example, the therapist skipped directly to question 16 without assessing the full context of repetitive thoughts or behaviors, and didn't probe further on substance use beyond the standard questions.",
        "clinical_relevance": "The therapist's questions generally aligned with DSM-5 criteria, but there were moments of slight inaccuracies or vague phrasing. For instance, when asking about 'sleeping less than usual but still have a lot of energy,' the patient actually reported being exhausted, which might have been better explored with a follow-up question. Additionally, some questions could have been phrased more precisely to align with DSM-5 terminology, such as differentiating between anxiety and fear more clearly.",
        "consistency": "The dialogue generally flows logically, with each question naturally following from previous responses. However, there were minor logical inconsistencies, such as not following up on the patient's report of muscle aches and pains (question 9) with additional questions about health-related distress. The conversation mostly maintains coherence, but could benefit from smoother transitions and more probing questions.",
        "diagnostic_justification": "The diagnosis of Major Depressive Disorder (MDD) with associated somatic symptoms and passive suicidal ideation is clearly justified by the patient's responses. The therapist explicitly linked symptoms like anhedonia, depressed mood, psychomotor retardation, and cognitive impairments to DSM-5 criteria. The reasoning provided is clinically sound, and alternative diagnoses were considered and ruled out (e.g., no psychotic features).",
        "empathy": "The therapist's responses consistently showed empathy and a natural conversational style. The therapist acknowledged the patient's distress ('You just want to feel better'), used non-judgmental language, and provided a supportive tone throughout the conversation. The therapist tailored responses to the patient's emotional state, demonstrating warmth and understanding."
      },
      "overall_comments": "The therapist demonstrated a strong clinical approach, effectively diagnosing and planning treatment for the patient. While there were minor omissions in DSM-5 dimension coverage and some questions could have been phrased more precisely, the conversation overall was empathetic, well-structured, and clinically relevant. The diagnosis and treatment recommendations were clearly justified and aligned with DSM-5 criteria.",
      "average_score": 4.4,
      "diagnosis_accuracy": {
        "matches_profile": true,
        "confidence": 5,
        "explanation": "The diagnosis explicitly mentions Major Depressive Disorder (MDD) with associated somatic symptoms, which aligns with the expected profile of depression. The symptoms described, such as anhedonia, depressed mood, psychomotor retardation, sleep disturbance, and cognitive impairments, are characteristic of depression.",
        "classification": "depression"
      },
      "diagnosis_classification": {
        "expected_profile": "depression",
        "classified_as": "depression",
        "match": true,
        "confidence": 5
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.116318941116333
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.5275729920493553,
        "local_coherence": 0.5446504436266177,
        "window_coherence": 0.5715784760661987
      },
      "readability": {
        "flesch_kincaid_grade": 9.0,
        "gunning_fog_index": 4.95,
        "flesch_reading_ease": 52.19
      },
      "diversity": {
        "distinct_1": 0.5185185185185185,
        "distinct_2": 0.9141048824593129,
        "distinct_3": 0.9746606334841629
      }
    },
    "diagnosis_evaluation": {
      "expected": "depression",
      "predicted": "<sym>Little interest or pleasure in activities, persistent hopelessness, and unexplained physical pain</sym> are woven through your words. Your <sym>4 AM wakefulness</sym>, <sym>cognitive fog</sym>, and the <sym>heavy blanket</sym> over your chest paint a picture of profound distress. Your <quote>\"I just want to feel better\"</quote> underscores the urgency of your suffering. You\u2019re not alone in this\u2014understanding and care are here.  \n\n**Diagnosis:** Major Depressive Disorder (MDD) with associated somatic symptoms, with <med>passive suicidal ideation</med> requiring immediate attention.  \n\n**Reasoning:**  \n- **Major Depressive Disorder (MDD):** The constellation of <sym>anhedonia</sym>, <sym>depressed mood</sym>, <sym>psychomotor retardation</sym> (e.g., <quote>\"can\u2019t focus on emails\"</quote>, <sym>sleep disturbance</sym> (early morning awakenings), and <sym>cognitive impairments</sym> meet DSM-5 criteria for MDD.  \n- **Somatic Symptoms:** Unexplained pain (musculoskeletal aches) and <sym>health-related distress</sym> raise SSD considerations, but these symptoms align more with <med>depressive somatic presentation</med> without disproportionate health preoccupation (no excessive health-related behaviors or thoughts beyond symptom reports).  \n- **Suicidal Risk:** <sym>Passive ideation</sym> (<quote>\"better off without me\"</quote>) requires urgent assessment of lethality and safety planning.  \n- **Rule-outs:** No <med>psychotic features</med> (denies hallucinations/persecutory thoughts Q12\u2013Q13). Minimal anxiety features, which appear secondary to depressive dysphoria (Q6\u2013Q8).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. **Immediate Suicidal Risk Assessment:**  \n   - Conduct structured risk evaluation (e.g., Columbia-Suicide Severity Rating Scale) to assess intent/plan.  \n   - Develop a safety plan with crisis contacts and limit access to means if indicated.  \n\n2. **Pharmacological Intervention:**  \n   - Initiate <med>SSRIs</med> (e.g., escitalopram) for MDD, targeting anhedonia/sleep/cognition.  \n   - Rule out medical contributors to pain (e.g., vitamin D levels, thyroid function) despite prior testing.  \n\n3. **Psychotherapy:**  \n   - Start <med>Cognitive Behavioral Therapy (CBT)</med> for depressive cognitions and behavioral activation.  \n   - Integrate <med>mindfulness-based stress reduction</med> for somatic symptom management.  \n\n4. **Collaborative Care:**  \n   - Partner with primary care for ongoing pain monitoring, emphasizing empathy to counter <quote>\"not taken seriously\"</quote> reports.  \n   - Consider <med>SSRI augmentation</med> for pain if unresolved after 2\u20134 weeks of treatment.  \n\n5. **Monitoring:**  \n   - Weekly mood monitoring (PHQ-9, GAD-7) to track symptom trajectory.  \n   - Reassess suicidal ideation at every visit.  \n\nYou deserve compassion and effective care\u2014this is not a phase, and recovery is possible with the right support.",
      "matches": true,
      "classification": "depression",
      "classification_confidence": 5
    }
  }
}